Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

How Abbott is making good on investor promises

September 22, 2017 By Chris Newmarker

AbbottAbbott (NYSE: ABT) has won FDA approval of MR-compatible ICDs – an indication that it could be making good executing on key priorities it inherited when it acquired St. Jude Medical for $25 billion early this year.

The news today “lends incremental credibility to our thesis that ABT can and will have a positive impact on STJ execution,” Stifel analysts indicated in a new report that an Abbott spokesperson shared with MDO and MassDevice. The analysts pointed to the fact that Abbott was able to achieve the approval despite an ongoing, legacy St. Jude Medical Rhythm Management manufacturing warning letter with FDA.

The new MR-conditional label from FDA applies to the Ellipse ICD and the Tendril MRI pacing lead and the Durata and Optisure high-voltage leads.

St. Jude Medical (now Abbott) has lagged behind competitors when it comes to MRI-safe pacemakers and ICDs. Medtronic, for example, won FDA approval in 2015 of its Evera MRI SureScan device, touted as the first MRI-safe implantable cardiac defibrillator approved in the U.S.

There was also speculation last year that the Abbott-St. Jude merger offered an opportunity for competitors because of the management resources it would suck up. “I think both Boston Scientific and Medtronic are licking their lips in terms of potential market share that could come up for grabs,” Piper Jaffray analyst Brooks West said at the time, according to the Star Tribune of Minneapolis.

Abbott, though, has shown this year that it can execute on getting MR-compatible devices onto the market. It won FDA approval in February for magnetic resonance-conditional labeling for its Assurity MRI pacemaker and its Tendril MRI pacing lead, and now there’s the Ellipse ICD news.

“We’re on track with all of our key priorities, including growth contributions from recently launched products and achievement of important regulatory milestones across our pipeline. The integration of St. Jude continues to go very well, and we’re on track to achieve our projected synergy targets,” Abbott CEO Miles White said during a July earnings call with analysts, transcribed by Seeking Alpha.

Stifel analysts in their note today said they aren’t changing their numbers, but said their fourth-quarter –2% CRM growth projection could now prove conservative. The Ellipse approval, they said, is “highly positive on multiple fronts.”

“This approval would seem to have come a few months early relative to management guidance. And, we suspect with the FDA Warning Letter, some more-bearish investors may have anticipated a delay into 2018,” said Rick Wise, Mathew Blackman and Drew Ranieri at Stifel.

(Learn from some of the medical device industry’s top executives and experts at DeviceTalks Boston on Oct. 2.)

You may also like:

  • Big 100 largest medical device companies MDO
    The 20 Largest Medical Device Companies In the World
  • neon brain
    7 ways neurostimulation could make our lives better
  • cardiology research breakthroughs robotic heart sleeve Harvard
    Cardiology research breakthroughs you need to know

Comments

  1. fisher scientific products says

    November 28, 2017 at 5:40 pm

    I’m impressed, I have to admit. Seldom do I encounter a blog that’s
    equally educative and engaging, and without a doubt, you have hit the nail
    on the head. The issue is something that not enough people are speaking intelligently about.
    I’m very happy I found this in my search for something relating to this.

Related Articles Read More >

Logos of Creo Medical and Intuitive
Creo Medical inks collaboration agreement with Intuitive
A portrait of Zimmer Biomet CEO Bryan Hanson
Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
Mitsubishi Gas Chemical Company BD Oxycapt syringe
BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
AdvaMed
AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech